Alkaline phosphatase (ALP) is an enzyme whose elevated levels in blood tests may indicate certain cancers, particularly those affecting the liver or bones. This elevation occurs because cancerous cells often produce higher amounts of ALP or because tumors damage organs that normally contain this enzyme.
ALP is important for bone mineralization and liver function. It helps remove phosphate groups from molecules, a process called dephosphorylation. In bones, ALP aids in hardening, while in the liver, it assists with bile production. When cancer affects these organs, ALP levels can rise.
The three primary types of ALP are:
In cancer diagnosis, liver/bone ALP is most relevant. A specialized test called alkaline phosphatase 30 can distinguish between these types.
Cancers that commonly cause ALP elevation include:
| Cancer Type | Typical ALP Increase | Other Affected Organs |
|---|---|---|
| Liver cancer | 2-10 times normal levels | Liver |
| Bone cancer | 3-5 times normal levels | Bones |
| Metastatic cancer | Varies by location | Multiple organs |
Non-cancerous conditions like liver disease or bone disorders can also raise ALP levels. Doctors use additional tests to determine the cause.
ALP testing helps doctors monitor treatment progress and detect cancer recurrence. For example, in prostate cancer, elevated ALP levels often indicate bone metastases. The American Cancer Society notes that ALP tests are part of standard tumor marker panels for several cancer types.
Many people assume that any ALP elevation automatically means cancer. However, other conditions like pregnancy, bone growth in children, or liver diseases can also increase levels. A single elevated reading requires follow-up testing for accurate diagnosis.